McKesson Ventures has returned to back a $40m round for Lightship, having co-led a $20m series B last year.
Amdocs and Comcast contributed to deep learning software provider Neural Magic's $30m series A round while packaging producer Creapaper completed a series B featuring Ranpak.
SoftBank Vision Fund 2 led autistic childcare platform developer Elemy’s latest round, which valued it at $1.15bn.
Prosus Ventures has returned to back an equity and debt round for the homecare management platform developer secured at a $1.25bn valuation.
Helena backed Twin Health, the developer of a metabolic digital twin platform, in a round reportedly valuing it at $740m.
M Ventures has returned to back the cancer therapeutics developer’s $75.5m round, five years after taking part in its series A.
Data collaboration software producer Duality Technologies, e-commerce logistics provider Pandion and cybersecurity software developer Adaptive Shield each raised $30m.
The cancer drug developer has closed an initial public offering which took place alongside a $160m SoftBank-led private placement.
Novartis Venture Fund returned for the small molecule drug developer’s series B round, tipping its total funding to over $100m.
The immuno-oncology drug developer’s prospective initial public offering would mark exits for Takeda, Merck Group, Ipsen and Merck & Co.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
